What are the recommendations for administration of chickenpox (varicella) vaccinations?

Updated: Aug 31, 2020
  • Author: Anthony J Papadopoulos, MD; Chief Editor: Dirk M Elston, MD  more...
  • Print

A live attenuated varicella vaccine (Oka strain) was approved by the US Food and Drug Administration in 1995 for prophylactic use in healthy children and adults. Vaccination recommendations consist of 1 dose for healthy children aged 12-18 months and 2 doses, in a 4- to 8-week interval, in susceptible persons older than 13 years. Studies in Japan point to high seroconversion rates and long-term immunity in children after vaccination. [22, 23, 24, 25, 26, 32] The need for revaccination, or a booster immunization, will be addressed after more long-term studies have been completed.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!